Zobrazeno 1 - 10
of 826
pro vyhledávání: '"Refractory chronic urticaria"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lee, Hyun-Young, Jeon, Hyun-Seob, Jang, Jae-Hyuk, Lee, Youngsoo, Shin, Yoo Seob, Nahm, Dong-Ho, Park, Hae-Sim, Ye, Young-Min
Publikováno v:
In Journal of Allergy and Clinical Immunology: Global May 2024 3(2)
Autor:
LaCava, Anthony F.1 (AUTHOR) anthonylacavajr@gmail.com, Fadugba, Olajumoke O.2 (AUTHOR)
Publikováno v:
Allergy, Asthma & Clinical Immunology. 8/29/2023, Vol. 19 Issue 1, p1-6. 6p.
Autor:
Hyun-Young Lee, PhD, Hyun-Seob Jeon, MD, Jae-Hyuk Jang, MD, Youngsoo Lee, MD, Yoo Seob Shin, MD, PhD, Dong-Ho Nahm, MD, PhD, Hae-Sim Park, MD, PhD, Young-Min Ye, MD, PhD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 2, Pp 100245- (2024)
Background: Treating chronic urticaria (CU) that is unresponsive to H1-antihistamines (H1AHs) is challenging, and the real-world effectiveness of omalizumab remains unclear. Objective: Our aim was to evaluate the real-world effectiveness of omalizuma
Externí odkaz:
https://doaj.org/article/e308eb266fca408b8f2c2386328e1f77
Publikováno v:
Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research). 2024, Vol. 15 Issue 8, p285-291. 7p.
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 19, Iss 1, Pp 1-6 (2023)
Abstract Background While both the AAAAI/ACAAI and the EAACI/GA2LEN/EuroGuiDerm/APAAACI guidelines recommend starting cyclosporine for patients with chronic urticaria who have had an inadequate response to omalizumab, many clinicians are hesitant to
Externí odkaz:
https://doaj.org/article/8d60e8922dfc498289e80753a9f0a0a7
Autor:
Rijal H; Queen's University School of Medicine, Kingston, ON, Canada., Sood S; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Bagit A; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Maliyar K; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada., Abduelmula A; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada., Georgakopoulos JR; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada., Mufti A; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.; Department of Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Yeung J; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.; Department of Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Department of Dermatology, Women's College Hospital, Toronto, ON, Canada.; Probity Medical Research, Waterloo, ON, Canada.
Publikováno v:
Journal of cutaneous medicine and surgery [J Cutan Med Surg] 2024 Oct 24, pp. 12034754241291869. Date of Electronic Publication: 2024 Oct 24.
Autor:
Iolanda Alen Coutinho, Frederico Soares Regateiro, Rosa Anita Fernandes, Joana Sofia Pita, Raquel Gomes, Constança Coelho, Ana Todo Bom
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 16, Iss 1, Pp 1-9 (2020)
Abstract Background Chronic urticaria (CU) is defined as recurrent urticaria lasting for more than 6 weeks. Objectives We aimed to characterize the phenotypes of patients with CU refractory to standard dose anti-H1 antihistamine treatment and search
Externí odkaz:
https://doaj.org/article/d3c4dd7f4b244db987104368542ffdda
Autor:
Seth, Sharon, Khan, David A.
Publikováno v:
In The Journal of Allergy and Clinical Immunology: In Practice January-February 2017 5(1):165-170
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.